New Novavax COVID-19 vaccine could address inequity and demand - The Well : The Well
Coronavirus Today: Can Novavax persuade holdouts to get vaccinated? - Los Angeles Times
Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays | Science | AAAS
Novavax - News, Articles etc. - European Pharmaceutical Review
EU approves Novavax shot as fifth COVID vaccine | Coronavirus pandemic News | Al Jazeera
CDC panel recommends Novavax vaccine as BA.5 gains more ground | CIDRAP
Novavax publishes positive initial data for first combined Covid and flu vaccine | Financial Times
mRNA vaccines ease breakthrough COVID; Novavax helps block variant | CIDRAP
Analysts share what new Novavax CEO John Jacobs means for its Covid vaccine - Washington Business Journal
How Novavax's COVID vaccine gained a cult-like following before US approval | Fortune
New Novavax Shot Could Appeal to Pro-Life Christian Skeptics | News & Reporting | Christianity Today
Novavax, fashionably late to the COVID-19 vaccine party, could still reap $5B in 2022: analyst | Fierce Pharma
Mixing COVID-19 vaccines appears to boost immune responses | Science | AAAS
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Covid vaccine makers CureVac and Novavax appoint new chiefs | Financial Times
Novavax targets May approval for COVID-19 vaccine in the U.S. | Fierce Biotech
Novavax Initiates Pediatric, Adolescent COVID-19 Vaccine Study
Novavax COVID vaccine shows 90.4% efficacy against infection | CIDRAP
Novavax Investor Relations - Press releases & statements
